KMDA - CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.